Stay updated on Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page.

Latest updates to the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.5%

- Check17 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check24 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.7.0 was added to the study history, replacing the previous v3.6.6 entry. This reflects an update to the page’s revision history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe record history now shows a new revision entry v3.6.6. The previous revision v3.6.5 has been removed from the history.SummaryDifference0.1%

Stay in the know with updates to Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Lixivaptan after Tolvaptan in ADPKD Clinical Trial page.